Elevated serum magnesium associated with SGLT2 inhibitor use in type 2 diabetes patients: a meta-analysis of randomised controlled trials

Aims/hypothesis By analysing available evidence from randomised controlled trials (RCTs), we aimed to examine whether and to what extent sodium–glucose cotransporter 2 (SGLT2) inhibitors affect serum electrolyte levels in type 2 diabetes patients. Methods We searched PubMed, EMBASE, Cochrane Central...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Diabetologia 2016-12, Vol.59 (12), p.2546-2551
Hauptverfasser:	Tang, Huilin, Zhang, Xi, Zhang, Jingjing, Li, Yufeng, Del Gobbo, Liana C., Zhai, Suodi, Song, Yiqing
Format:	Artikel
Sprache:	eng
Schlagworte:	Benzhydryl Compounds - therapeutic use Bias Canagliflozin - therapeutic use Diabetes Diabetes Mellitus, Type 2 - blood Diabetes Mellitus, Type 2 - drug therapy Drug dosages Electrolytes Female Glucose Glucosides - therapeutic use Human Physiology Humans Internal Medicine Kidney diseases Magnesium - blood Male Medicine Medicine & Public Health Meta-analysis Metabolic Diseases Potassium Public health Randomized Controlled Trials as Topic Regression analysis Short Communication Sodium-Glucose Transporter 2 Inhibitors Thiophenes - therapeutic use
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!